Stay updated on ARO-APOC3 in Mixed Dyslipidemia Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag on the page updated from v3.5.3 to v3.5.4, indicating a metadata/version update. This change represents an internal versioning update and does not alter the study details or displayed information.
    Difference
    0.0%
    Check dated 2026-05-16T09:08:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a site update rather than a change to the ClinicalTrials.gov study details.
    Difference
    0.0%
    Check dated 2026-04-25T05:29:50.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision notes show the current release as Revision: v3.5.2 with dates 2026-04-14, 2026-04-10, and 2026-04. A prior Revision: v3.5.0 dated 2026-02-24, 2026-02-06, and 2026-02 has been removed.
    Difference
    0.2%
    Check dated 2026-04-18T03:50:25.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.0%
    Check dated 2026-03-20T05:19:06.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-05T19:47:13.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Results were posted on 2026-02-24 and the study record was updated to reflect the new title 'Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia (MUIR)' with expanded design details and endpoints.
    Difference
    5%
    Check dated 2026-02-26T14:41:23.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in Mixed Dyslipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.